Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kempe, S., Führer-Sakel, D. Moderne TKI-Therapie: zielgerichtet Rezeptortyrosinkinasen abschalten. Im Fokus Onkologie 24, 37–40 (2021). https://doi.org/10.1007/s15015-021-3378-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15015-021-3378-6